A Review of the Incidence and Coincidence of Uterine and Mammary Tumors in Wistar and Sprague-Dawley Rats Based on the RITA Database and the Role of Prolactin

Toxicologic Pathology

Volumn 40, Issue 6, 2012, Pages 926-930

  Harleman, Johannes H ^a   Hargreaves, Adam ^a   Andersson, Håkan ^b   Kirk, Sarah ^a  

^a ASTRAZENECA   (United Kingdom)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

interdependency; mammary tumors; prolactin; rats; Sprague Dawley; uterine tumors; Wistar

Indexed keywords

PROLACTIN;

BREAST TUMOR; CORRELATION ANALYSIS; FEMALE; MIXED TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REFERENCE DATABASE; REVIEW; SPRAGUE DAWLEY RAT; TUMOR CLASSIFICATION; UTERUS TUMOR; WEIGHT REDUCTION; WISTAR RAT;

ANIMALS; FEMALE; INCIDENCE; MAMMARY NEOPLASMS, ANIMAL; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; UTERINE CERVICAL NEOPLASMS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84865973830     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623312444621     Document Type: Article

References (34)

1. Alison R. H. Capen C. C. Prentice D. E. (1994). Neoplastic lesions of questionable significance to humans. Toxicol Pathol 22, 179–86.
2. Ben-Jonathan N. LaPensee C. R. LaPensee E. W. (2008). What can we learn from rodents about prolactin in humans. Endocrine Rev 29, 1–41.
3. Blankenstein M. A. Broerse J. J. van Zwieten M. J. van der Molen H. J. (1984). Prolactin concentration in plasma and susceptibility to mammary tumors in female rats from different strains treated chronically with estradiol-17beta. Breast Cancer Res Treatment 4, 137–41.
4. Burek J. D. Patrick D. H. Gerson R. J. (1988). Weight-of-biological evidence approach for assessing carcinogenicity. In: Carcinogenicity (Grice H. C. Cimina J. L., eds.), pp. 83–95. Springer-Verlag, New York.
5. Cohen S. M. Klauning J. Meek M. E. Hill R. N. Pastoor T. Lehman-McKeeman L. Bucher J. Longfellow D. G. Seed J. Dellarco V. Fenner-Chip P. Patton D. (2004). Evaluating the human relevance of chemically induced animal tumours. Toxicol Sci 78, 181–86.
6. J.E., Demaria, G.M., Nagy, A.A., Lerant, M.M.E., Fekete, C.W., Levenson, M.E., Freeman, Dopamine transporters participate in the physiological regulation of prolactin, Endrocrinology, (2000), 141, 366-374
7. Dudley S. D. (1982). Responsiveness to estradiol in central nervous system of aging female rats. Neurosci Biobehav Rev 6, 39–45.
8. Ettlin R. A. Prentice D. E. (2002). Unexpected tumour findings in lifetime rodent bioassay studies—what to do? Toxicol Lett 128, 17–33.
9. Everitt A. V. (1980). The neuroendocrine system and aging. Gerontology 26, 108–19.
10. Freeman M. E. Kanycska B. Lerant A. Nagy G. (2000). Prolactin: structure, function and regulation of secretion. Physiol Rev 80, 1523–631.
11. Gambrell R. D. Bagnell C. A. Greenblatt R. B. (1983). Role of oestrogens and progesterone in the ethiology and prevention of endometrial cancer: review. Am J Obstet Gynecol 146, 696–707.
12. Gopinath C. Prentice D. E. Lewis D. J. (1987). Atlas of Experimental Toxicological Pathology. MTP Press, Lancaster.
13. Grattan D. R. Steyn F. J. Kokay I. C. Anderson G. M. Bunn S. J. (2008). Pregnancy-induced adaption in the neuroendocrine control of prolactin secretion. J Neuroendocrinol 20, 497–507.
14. Greaves P. (2007). Histopathology of Preclinical Toxicity Studies. Academic Press, New York.
15. Greaves P. Faccini J. M. (1984). Rat histopathology. Elsevier, Amsterdam.
16. Griffith R. W. (1977). Bromocriptine and uterine neoplasia. Br Med J 2, 1605.
17. Hargreaves A. Harleman J. H. (2011). Preclinical risk assessment of drug induced hypo- and hyperprolatemia. J Appl Toxicol 31, 599–607.
18. Keenan C. Elmore S. Francke-Caroll S. Kemp R. Kerlin R. Peddadda S. Fletcher J. Rinke M. Schmidt S. P. Taylor I. Wolf D. (2009). Best practices for use of historic control data of proliferative rodent lesions. Toxicol Pathol 37, 679–93.
19. Keenan K. P. Smith P. F. Hertzog P. Soper K. Ballam G. C. Clark R. L. (1994). The effects of overfeeding and dietary restriction on Sprague-Dawley rat survival and early pathology biomarkers of aging. Toxicol Pathol 22, 300–15.
20. Keenan K. P. Soper K. A. Hertzog P. R. Gumprecht L. A. Smith P. F. Mattson B. A. Ballam G. C. Clark R. L. (1995). Diet, overfeeding, and moderate dietary restriction in control Sprague-Dawley rats: II. Effects on age-related proliferative and degenerative lesions. Toxicol Pathol 23, 287–302.
21. Keenan K. P. Soper K. A. Smith P. F. Ballam G. C. Clark R. L. (1995). Diet, overfeeding, and moderate dietary restriction in control Sprague-Dawley rats: I. Effects on spontaneous neoplasms. Toxicol Pathol 23, 269–286.
22. Kovacs K. Horwath E. Ilse R. G. Ezrin C. Ilse D. (1977). Spontaneous pituitary adenomas in aging rats: a light microscopic, immunocytological and fine structural study. Beitr Pathol 161, 1–16.
23. Lu K. H. Hopper B. R. Vargo T. M. Yen S. S. C. (1979). Chronological changes in sex steroids, gonadotropin and prolactin secretion in aging female rats displaying different reproductive states. Biol Reprod 21, 193–203.
24. Mohr U. Bader R. Ernst H. Ettlin R. Gembardt C. Harleman J. H. Hartig F. Jahn W. Kaliner G. Karbe E. Kaufmann W. Krieg K. Krinke G. Küttler K. Landes C. Mettler F. Morawietz G. Notman J. Püschner H. Qureshi S. Reznik G. Rittinghausen S. Tuch K. Urwyler H. Weisse G. Weisse I. Zehnder J. (1990). Tumor Registry Data Base: suggestions for a systematized nomenclature for pre-neoplastic and neoplastic lesions in rats. Exp Pathol 38, 1–18.
25. Neumann F. (1991). Early factors for carcinogenesis in sex hormone sensitive organs. Mut Res 248, 341–56.
26. O’Connor J. C. Plowchalk D. R. Van Pelt C. S. Davis L. G. Cook J. C. (2000). Role of prolactin in chloro-s-triazine rat mammary tumorigenesis. Drug Cem Toxicol 23, 575–601.
27. Reymond M. J. Donda A. Lemarchand-Béraud T. (1989). Neuroendocrine aspects of aging: experimental data. Horm Res 31, 32–38.
28. Richardson B. P. Turkali I. Flueckiger E. (1984). Bromocriptine. In: Safety Testing of New Drugs (Laurence D. R. McLean A. E. M. Wheatherall M., eds.), pp. 19–63. Academic Press, London.
29. F.F.C., Roe, P.N., Lee, G., Conybeare, D., Kelly, B., Matter, D., Prentice, G., Tobin, The Biosure study: influence of composition of diet and food consumption on longevity, degenerative diseases and neoplasia in Wistar rats studied for up to 30 months post weaning, Fd Cem Toxic, (1995), 33, s1, 100
30. Sánchez H. L. Silva L. B. Portiansky E. L. Goys R. G. Zuccolilli G. O. (2003). Impact of very old age on hypothalamic dopaminergic neurons in the female rat: a morphometric study. J Comp Neurol 458, 319–25.
31. Sinha Y. N. Gilligan T. A. Barkley M. S. (1984). Inhibition of prolactin secretion by moderate and high doses of testosterone. Proc Society Exp Biol Med 175, 438–43.
32. Smith M. S. McLean B. K. Neill J. D. (1976). Prolactin: the initial luteotropic stimulus of pseudopregnancy in the rat. Endocrinology 98, 1370–77.
33. Tucker M. J. (1997). Diseases of the Wistar Rat. Taylor and Francis, London.
34. Welsch C. W. Nagasawa H. Meites J. (1970). Increased incidence of spontaneous mammary tumors in female rats with induced hypothalamic lesions. Cancer Res 30, 2310–13.